I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Tom Farrand has worked throughout his career at the intersection of AI and the life sciences.

First at IBM helping university hospitals to use supercomputers to model 3D heart scans at higher resolutions.

Then he joined leading startups and led the roll out of AI infrastructure for Janssen, Medtronic and Exscientia.

Now as CEO and Co-founder of Delfa he's building AI agents which automate clinical operations, starting in patient recruitment. His mission is clear: to accelerate access to life‑saving treatments by reimagining how patients connect with trials.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today, I’m joined by Poorya Amini, founder and CEO of Risklick, a Swiss digital health company that’s redefining how clinical trial protocols are designed.

Poorya’s journey spans veterinary medicine, a PhD in pharmacology, and hands‑on experience managing cardiology trials at the University of Bern. In 2019, he launched Risklick to tackle one of pharma’s biggest bottlenecks: protocol inefficiency.

Risklick’s flagship product, Protocol AI™, draws on a database of over 800,000 clinical trials to cut protocol development time by 50%, reduce amendments by 20%, and shorten implementation by 40%.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Anna Maxwell is a mission-driven founder, pharmacist and entrepreneur dedicated to widening access to medicines and empowering people to take more control of their health.

She is the CEO and Founder of Maxwellia, one of the UK’s most ambitious emerging consumer healthcare companies, on a mission to become a Top 50 global challenger brand in self-care.

With more than 30 years’ experience in retail pharmacy, consumer healthcare marketing and commercialising over-the-counter (OTC) medicines, Anna specialises in transforming prescription medicines into trusted, pharmacy-ready brands through the highly regulated process of reclassification.

By unlocking the untapped value of legacy drugs, Maxwellia is creating the blockbuster OTC medicine brands of the future and reshaping how people manage everyday health.

As a female founder, she has demonstrated what’s possible when purpose and commercial discipline meet relentless ambition

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Matt Veatch is President and COO of Navidence, and a driving force behind the Real World Wednesdays podcast—a weekly forum that’s reshaping how we think about real-world data (RWD) and real-world evidence (RWE).

With more than 25 years of experience advising life sciences organizations, Matt brings a rare blend of operational insight and visionary thinking to the table.

He’s a board member of the Decentralized Trials & Research Alliance (DTRA) and is a regular voice at global summits and conferences.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Nives Rombini is a scientist, data strategist, and founder whose career bridges molecular biology, immunology, and advanced analytics.

Nives leads Navis Bio, a venture dedicated to harnessing data-driven insights for biomedical innovation.

Rombini’s professional journey began with Swisscom, where she honed her skills in data engineering and AI applications before transitioning to the pharmaceutical sector.

Fluent in German, Italian, English, and French, Rombini embodies a cosmopolitan perspective that enriches her scientific collaborations.

With a foundation in both laboratory research and computational analysis, she is recognized for her ability to connect disciplines, close evidence gaps, and inspire innovation at the intersection of biology and data science.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Alan Salter is a professional whose career spans military service, international business and healthcare leadership.

A proud U.S. Navy veteran, Alan served with distinction before transitioning into the private sector, where he established a management consulting company Caravel International Partners, a strategic venture based in Chicago.

In addition, Alan is also President of NRP (Nonprofit Resource Partners) which supports companies by providing fractional(temp) staffing on a not-for-profit basis.

His time in the Navy instilled a deep sense of discipline, resilience, and global perspective—qualities that continue to shape his approach to leadership and governance.

Alan’s journey reflects a rare blend of service and strategy. From navigating the rigors of military life to steering entrepreneurial ventures, he brings a grounded yet visionary lens to the evolving role of pharmacy and healthcare delivery.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Today, we’re joined by Maya Zlatanova, a visionary leader in clinical research innovation and host of the podcast Trials with Maya Z, where she explores the future of trials with global experts and patient advocates.

As CEO and co-founder of FindMeCure and TrialHub, Maya is on a mission to make clinical trials more accessible, transparent, and patient-centric.

Her platforms empower sponsors and CROs to design smarter trials by integrating real-world data, local standard-of-care insights, and feasibility analytics. With many years of experience in clinical trial regulations and patient recruitment, Maya has trained health ministries, pharma teams, and global organizations, including the UN and NHS.

Whether through software, storytelling, or systems change, she champions a future where trials are not just efficient—but human-centered, inclusive, and impactful.

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time.

In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear?

Dr. Daniel Fox, CEO of CRPN Central is a leader redefining clinical research through decentralised, patient-first platforms.

With a background in medicine, policy, and digital innovation, Dr. Fox is building scalable ecosystems that restore trust and transparency in trials.

His work bridges the technical and the human, empowering communities to take part in research that reflects their needs and values.

CRPN’s network spans thousands of professionals, and its mission is clear: restore trust, streamline operations, and make trials truly inclusive.

From platform design to public health advocacy, Dr. Fox brings clarity to complexity and compassion to clinical strategy.